Edward F. Elslager

2.2k total citations
119 papers, 1.6k citations indexed

About

Edward F. Elslager is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Edward F. Elslager has authored 119 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Organic Chemistry, 35 papers in Molecular Biology and 12 papers in Infectious Diseases. Recurrent topics in Edward F. Elslager's work include Synthesis and Characterization of Heterocyclic Compounds (52 papers), Synthesis and biological activity (30 papers) and Quinazolinone synthesis and applications (27 papers). Edward F. Elslager is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (52 papers), Synthesis and biological activity (30 papers) and Quinazolinone synthesis and applications (27 papers). Edward F. Elslager collaborates with scholars based in United States and Austria. Edward F. Elslager's co-authors include Leslie M. Werbel, Donald F. Worth, Judith L. Johnson, John Davoll, Frank H. Tendick, Wilbur R. Leopold, Robert Jackson, Marland P. Hutt, Joan L. Shillis and H. D. Hollis Showalter and has published in prestigious journals such as Nature, Journal of the American Chemical Society and JNCI Journal of the National Cancer Institute.

In The Last Decade

Edward F. Elslager

117 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward F. Elslager United States 20 943 453 223 186 114 119 1.6k
Leslie M. Werbel United States 22 1.0k 1.1× 622 1.4× 178 0.8× 265 1.4× 98 0.9× 108 1.7k
Suely Lins Galdino Brazil 22 606 0.6× 513 1.1× 136 0.6× 90 0.5× 127 1.1× 84 1.5k
Jaime Charris Venezuela 21 1.1k 1.2× 508 1.1× 228 1.0× 83 0.4× 137 1.2× 101 1.6k
Christoph Reiter Germany 15 357 0.4× 380 0.8× 240 1.1× 130 0.7× 45 0.4× 16 989
Y. Fulmer Shealy United States 27 900 1.0× 1.2k 2.6× 68 0.3× 186 1.0× 98 0.9× 119 2.0k
Yasheen Zhou United States 15 623 0.7× 418 0.9× 81 0.4× 92 0.5× 122 1.1× 25 1.1k
S.K. Puri India 31 1.5k 1.6× 720 1.6× 878 3.9× 171 0.9× 146 1.3× 95 2.9k
Linda L. Wotring United States 22 684 0.7× 632 1.4× 46 0.2× 131 0.7× 36 0.3× 69 1.5k
Philip F. Hughes United States 28 501 0.5× 925 2.0× 96 0.4× 105 0.6× 87 0.8× 76 2.0k
Leon Goodman United States 30 1.8k 2.0× 1.6k 3.5× 56 0.3× 145 0.8× 177 1.6× 175 2.8k

Countries citing papers authored by Edward F. Elslager

Since Specialization
Citations

This map shows the geographic impact of Edward F. Elslager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward F. Elslager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward F. Elslager more than expected).

Fields of papers citing papers by Edward F. Elslager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward F. Elslager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward F. Elslager. The network helps show where Edward F. Elslager may publish in the future.

Co-authorship network of co-authors of Edward F. Elslager

This figure shows the co-authorship network connecting the top 25 collaborators of Edward F. Elslager. A scholar is included among the top collaborators of Edward F. Elslager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward F. Elslager. Edward F. Elslager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, C. C., Edward F. Elslager, Leslie M. Werbel, & Wilbur R. Leopold. (1986). Pyrazole derivatives. 5. Synthesis and antineoplastic activity of 3-(2-chloroethyl)-3,4-dihydro-4-oxopyrazolo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide and related compounds. Journal of Medicinal Chemistry. 29(8). 1544–1547. 18 indexed citations
2.
Colbry, Norman L., Edward F. Elslager, & Leslie M. Werbel. (1985). Folate antagonists. 21. Synthesis and antimalarial properties of 2,4-diamino-6-(benzylamino)pyrido[3,2-d]pyrimidines. Journal of Medicinal Chemistry. 28(2). 248–252. 13 indexed citations
3.
Colbry, Norman L., Edward F. Elslager, & Leslie M. Werbel. (1984). Synthesis and antimalarial properties of 2,4‐diamino‐6‐[(aryl)thio, sulfinyl, and sulfonyl]pyrido[3,2‐d]pyrimidines. Journal of Heterocyclic Chemistry. 21(5). 1521–1525. 19 indexed citations
4.
Elslager, Edward F., et al.. (1980). Folate antagonists. 16. Antimalarial and antibacterial effects of 2,4‐diamino‐6‐[(heterocyclic)thio, sulfinyl, and sulfonyl]quinazolines. Journal of Heterocyclic Chemistry. 17(1). 129–136. 5 indexed citations
5.
Worth, Donald F., Judith L. Johnson, Edward F. Elslager, & Leslie M. Werbel. (1978). Antimalarial drugs. 38. Folate antagonists. 10. Synthesis and antimalarial effects of 6-[[(aryl and aralkyl)amino]methyl]-2,4-pteridinediamines and -pteridinediamine 8-oxides. Journal of Medicinal Chemistry. 21(4). 331–337. 5 indexed citations
6.
7.
Elslager, Edward F., et al.. (1972). Folate antagonists. 6. Synthesis and antimalarial effects of fused 2,4‐diaminothieno[2,3‐d]pyrimidines. Journal of Heterocyclic Chemistry. 9(4). 775–782. 53 indexed citations
8.
9.
10.
Werbel, Leslie M., et al.. (1969). Notes. 2-(Alkyl- and Arylamino)-5-nitrothiazole Derivatives with Antiamebic, Antitrichomonal, and Antimalarial Properties. Journal of Medicinal Chemistry. 12(3). 521–524. 8 indexed citations
11.
12.
Bird, O. D., et al.. (1968). 1‐Aryl‐4,6‐diamino‐1,2‐dihydro‐s‐triazines. Contrasting effects on intestinal helminths, bacteria, and dihydrofolic reductase. Journal of Heterocyclic Chemistry. 5(3). 355–369. 8 indexed citations
13.
Elslager, Edward F., Marland P. Hutt, & Leslie M. Werbel. (1968). Potential antimalarial substances. Antimetabolites of pantothenic acid. Journal of Medicinal Chemistry. 11(5). 1071–1073. 3 indexed citations
14.
Elslager, Edward F., et al.. (1964). Synthetic Schistosomicides. VI. 4-Substituted 1-(Dialkylaminoalkylamino)naphthalenes1. Journal of Medicinal Chemistry. 7(5). 658–662. 6 indexed citations
15.
Thompson, Paul E., et al.. (1963). Laboratory Studies on 4,6-Diamino-1-(p-Chlorophenyl)-1,2-Dihydro-2,2-Dimethyl-s-Triazine Pamoate (CI-501) as a Repository Antimalarial Drug. American Journal of Tropical Medicine and Hygiene. 12(4). 481–493. 38 indexed citations
16.
Elslager, Edward F., et al.. (1963). [4-(Aminoalkylamino)-1-naphthylazo]heterocyclic Compounds, a Novel Class of Schistosomicides. Journal of Medicinal Chemistry. 6(2). 217–219. 4 indexed citations
17.
Werbel, Leslie M., et al.. (1963). N-Mono- and N,N-Dialkyl-N'-1-naphthylalkylenediamines. Journal of Medicinal Chemistry. 6(6). 637–646. 7 indexed citations
18.
Elslager, Edward F. & Frank H. Tendick. (1962). 4-(3-Chloro-9-acridinylamino)-α-amino-o-cresol 10-Oxides. Journal of Medicinal Chemistry. 5(6). 1153–1158. 2 indexed citations
19.
Elslager, Edward F., et al.. (1962). Intestinal Anthelmintics. I. The Preparation of Bis(2,4,5-trichlorophenol)-Piperazine Salt (Triclofenol Piperazine) and Other Phenol-Piperazine Salts. Journal of Medicinal Chemistry. 5(3). 642–646. 6 indexed citations
20.
Elslager, Edward F., et al.. (1961). Synthetic Schistosomicides. II. 1-[(Dialkylaminoalkyl)-methylamino]-4-methyl-10-thiaxanthenones1. The Journal of Organic Chemistry. 26(8). 2837–2841. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie M. Werbel Breakdown of academic impact, for papers by Suely Lins Galdino Breakdown of academic impact, for papers by Jaime Charris Breakdown of academic impact, for papers by Christoph Reiter Breakdown of academic impact, for papers by Y. Fulmer Shealy Breakdown of academic impact, for papers by Yasheen Zhou Breakdown of academic impact, for papers by S.K. Puri Breakdown of academic impact, for papers by Linda L. Wotring Breakdown of academic impact, for papers by Philip F. Hughes Breakdown of academic impact, for papers by Leon Goodman
Rankless by CCL
2026